NCT06819605: Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 46 planned
- Started
- 1 Mar 2025
- Primary completion
- 30 Oct 2028
- Arms
- Neoadjuvant group
- Results
- None posted
- 11 Feb 2025: Trial registered